Beta Drugs

Beta Drugs

1,710.15
+10.90
(0.64%)
Market Cap
1,715.30 Cr
EPS
42.02
PE Ratio
37.46
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
2,326.00
52 Week Low
1,201.00
PB Ratio
8.70
Debt to Equity
0.12
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,699.00
#1 4,05,967.50
35.44
#1 54,729.00
12.06
#1 10,980
-18.99
54.94
6,616.50
1,75,700.40
80.22
9,712.00
0.89
2,191
23.05
42.61
1,532.50
1,20,178.80
23.35
28,409.50
7.12
5,291
9.88
63.13
3,603.80
1,19,129.40
62.12
11,539.40
11.59
1,911
10.91
71.36
2,603.40
1,06,876.10
61.51
12,744.20
19.57
2,007
-10.91
60.17
1,277.90
1,05,615.00
#1 18.58
33,741.20
16.73
5,725
1.26
51.48
976.40
97,730.50
21.02
23,511.00
13.82
4,615
-0.19
53.23
1,951.00
88,662.90
27.33
22,909.50
#1 19.94
3,306
#1 112.49
51.88
33,780.00
73,480.10
52.02
6,684.70
10.80
1,414
27.83
50.65
1,122.80
64,707.10
18.71
31,378.10
17.55
3,366
-0.50
45.80
Forecast
Actual
Growth Rate
Revenue Growth
30.36 %
Net Income Growth
18.57 %
Cash Flow Change
32.29 %
ROE
-7.24 %
ROCE
-5.17 %
EBITDA Margin (Avg.)
-12.68 %

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
51
66
91
117
185
228
297
362
0
Expenses
41
54
73
91
141
174
236
292
0
EBITDA
10
12
18
25
44
54
61
70
0
Operating Profit %
19 %
18 %
20 %
21 %
23 %
23 %
20 %
19 %
0 %
Depreciation
2
3
4
7
7
10
10
13
0
Interest
1
1
3
2
2
2
3
7
0
Profit Before Tax
7
8
12
16
34
41
49
57
0
Tax
0
-0
3
4
10
10
12
15
0
Net Profit
7
8
9
12
25
31
36
42
0
EPS in ₹
7.82
9.30
9.79
12.20
25.82
31.95
37.90
42.02
0.00

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
50
83
107
118
158
198
254
436
Fixed Assets
13
18
44
40
55
63
65
89
Current Assets
32
43
56
68
97
128
178
331
Capital Work in Progress
1
15
0
3
0
0
0
0
Investments
0
0
0
0
0
0
0
60
Other Assets
35
50
63
75
103
136
190
0
Total Liabilities
50
83
107
118
158
198
254
436
Current Liabilities
14
32
37
33
49
63
85
103
Non Current Liabilities
3
9
13
16
17
13
12
136
Total Equity
33
41
57
69
92
123
157
197
Reserve & Surplus
24
32
48
59
83
113
148
187
Share Capital
9
9
10
10
10
10
10
10

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
12
-9
2
5
7
2
10
Investing Activities
-11
-21
-15
-6
-22
-19
-14
Operating Activities
17
0
8
19
30
23
31
Financing Activities
5
12
9
-8
-1
-3
-8

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Nov 2024
Dec 2024
Mar 2025
Promoter
66.68 %
66.68 %
66.68 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.32 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.63 %
21.88 %
22.72 %
22.86 %
22.86 %
22.59 %
22.61 %
22.60 %
22.52 %
22.24 %
22.37 %
22.33 %
22.35 %
21.96 %
21.70 %
21.63 %
21.60 %
21.81 %
Others
11.68 %
11.44 %
10.60 %
10.43 %
10.43 %
10.70 %
10.68 %
10.69 %
10.75 %
11.03 %
10.90 %
10.60 %
10.91 %
11.31 %
11.56 %
11.64 %
11.66 %
11.45 %
No of Share Holders
0
540
507
542
675
762
1,296
1,407
1,424
1,451
1,722
1,928
2,116
2,323
2,567
2,793
2,882
3,045

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,750.35 1,854.00
26 Mar 2025 BONUS Bonus
1:20
26 Mar 2025 1,850.00 1,935.00
21 Dec 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
21 Dec 2024 2,192.00 2,060.05
12 Nov 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Nov 2024 1,892.10 2,178.40
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 1,971.30 1,944.15
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 1,693.10 1,676.00

Technical Indicators

RSI(14)
Neutral
40.34
ATR(14)
Less Volatile
53.84
STOCH(9,6)
Oversold
12.81
STOCH RSI(14)
Neutral
25.64
MACD(12,26)
Bearish
-4.97
ADX(14)
Weak Trend
11.91
UO(9)
Bearish
54.16
ROC(12)
Downtrend And Accelerating
-5.88
WillR(14)
Oversold
-82.09